Physician profile
Stephen Winston
NPI 1376509158
$1,877.75
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $1,025 · 2021: $415.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $1,140.18 | 2020-2021 | |
| Abbott Laboratories | $233.17 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $138.66 | 2019-2020 | |
| Medtronic USA, INC. | $91.02 | 2019 | |
| Supernus Pharmaceuticals, INC. | $75.90 | 2019 | |
| Nevro Corp. | $62.63 | 2019 | |
| Boston Scientific Corporation | $42.57 | 2019-2021 | |
| Relievant Medsystems, INC. | $36.78 | 2020 | |
| Allergan, INC. | $27.22 | 2019-2020 | |
| Pfizer INC. | $15.54 | 2019 | |
| Grt US Holding, INC. | $14.08 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Winston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.